Friday’s deal with CSPC fits neatly within AstraZeneca’s business development strategy of upping investments in AI and in ...

Initial results from the ALXN1210-TMA-314 Phase III trial showed that UK pharma major AstraZeneca’s Ultomiris (ravulizumab) ...

The collaboration will focus on identifying pre-clinical candidates for high-priority targets, including a small molecule ...

MSFT, AZN, and BLK earn praise in fresh Zacks reports, with AI, pharma pipelines, and AUM growth fueling long-term outlooks.

MSFT, AZN, and BLK lead Zacks' top stock picks, while TAYD and GEOS show resilience despite microcap market pressures.

Cambridge: AstraZeneca has entered a strategic research collaboration with Shijiazhuang City-based CSPC Pharmaceuticals Group ...

Anglo-Swedish pharma major AstraZeneca has entered a strategic research collaboration with Shijiazhuang City-based CSPC ...

The collaboration aims to advance the discovery and development of novel oral candidates.

Drugmaker AstraZeneca revealed on Friday that it has entered a strategic research collaboration with Chinese firm CSPC Pharmaceuticals Group.

Plenty folk have an asthma puffer but few seem to know how to use it. Adherium says its Hailie device is improving compliance ...

AstraZeneca inks strategic collaboration with CSPC Pharmaceuticals focused on AI-enabled research: Cambridge, UK Saturday, June 14, 2025, 09:00 Hrs [IST] AstraZeneca has entered a ...